找回密码
 加入流式中文网

QQ登录

只需一步,快速开始

查看: 2643|回复: 0

长期生存的多发性骨髓瘤患者免疫指标分析

[复制链接]
发表于 2012-7-16 11:55:49 | 显示全部楼层 |阅读模式

亲爱的FLOWER,加入流式中文网,一起讨论,一起学习,享受更多福利吧!

您需要 登录 才可以下载或查看,没有账号?加入流式中文网

×
这篇文献用流式细胞术检测了长期存活的多发性骨髓瘤(MM)患者与初发MGUS、有症状的MM患者。主要检测了CD8+细胞毒T细胞、NK细胞、Treg、B细胞、树突状细胞等免疫系统指标,长期存活的MM患者中均高于其它两类患者,提示免疫机制对MM患者长期存活的重要性。<br><br><b><font size="4">Analysis of the immune system of multiple myeloma patients achieving long-term disease control, by multidimensional flow cytometry.</font></b><br>Pessoa-Magalhaes RJ&nbsp; &nbsp;, Vidriales MB&nbsp; &nbsp;, Paiva B&nbsp; &nbsp;, Gimenez CF&nbsp; &nbsp;, Garcia-Sanz R&nbsp; &nbsp;, Mateos MV&nbsp; &nbsp;, Gutierrez N&nbsp; &nbsp;, Lecrevisse Q&nbsp; &nbsp;, Blanco JF&nbsp; &nbsp;, Hernandez J&nbsp; &nbsp;, de Las Heras N&nbsp; &nbsp;, Martinez J&nbsp; &nbsp;, Roig M&nbsp; &nbsp;, da Costa ES&nbsp; &nbsp;, Ocio E&nbsp; &nbsp;, Perez-Andres M&nbsp; &nbsp;, Maiolino A&nbsp; &nbsp;, Nucci M&nbsp; &nbsp;, Delarubia J&nbsp; &nbsp;, Lahuerta JJ&nbsp; &nbsp;, San Miguel JF&nbsp; &nbsp;, Orfao A <br><br>Haematologica. 2012 Jul 6. [Epub ahead of print]<br><br><b><font size="3">Abstract</font></b><br>Background. Multiple myeloma remains largely incurable. However, a few patients experience ≥10-years relapse-free survival and can be considered as operationally cured. Interestingly, long-term disease control in multiple myeloma is not restricted to patients with complete response, since some revert into an MGUS profile. Design and Methods. We compared the distribution of multiple compartments of lymphocytes and dendritic cells in the bone marrow and peripheral blood of long-term disease control multiple myeloma (n=28) vs. both newly-diagnosed MGUS (n=23) and symptomatic multiple myeloma (n=23), and age-matched healthy adults (n=10). Results. Similarly to MGUS and symptomatic multiple myeloma, patients with long-term disease control showed an expansion of cytotoxic CD8+T-cells and NK-cells. However, bone marrow Tregs were reduced in long-term disease control vs. symptomatic multiple myeloma. Noteworthy, B-cells were depleted in MGUS and symptomatic multiple myeloma, while recovered in long-term disease control patients in both bone marrow and peripheral blood, due to an increase in normal bone marrow B-cell precursors and plasma cells, as well as pre-germinal center peripheral blood B-cells. The number of bone marrow dendritic cells and tissue macrophages significantly differed between long-term disease control and symptomatic multiple myeloma with a recovery trend in the former patient population towards levels similar to those found in healthy adults.Conclusions. In summary, our results indicate that long-term disease control multiple myeloma patients have a constellation of unique immune changes favoring both immune cytotoxicity and recovery of B-cell production and homing, suggesting an improved immunesurveillance.Keywords: myeloma, long term follow-up, immunesurveillance, T-cells, Tregs, B-cells.<br><br><br><br>PDF附件见: immun_system_MM.pdf (1.36 MB, 下载次数: 12, 售价: 2 流星) ,下载需要2颗流星(<a href="http://www.flowcyto.cn/bbs/forum.php?mod=viewthread&amp;tid=1520" target="_blank">为什么?</a>)<br>
使用流式中文网资料阅读器在线阅读,免流星,内容完全一样(<b>IE8和360浏览器无法显示,建议使用IE9和google chrome浏览器。</b><a href="http://www.flowcyto.cn/bbs/forum.php?mod=viewthread&amp;tid=1527" target="_blank">使用说明</a>)
<br>
<script type="text/javascript" src="flash/flowcytoview/swfobject.js"></script>
   <script type="text/javascript">
                        function thisMovie(movieName) {
                         if (navigator.appName.indexOf("Microsoft") != -1) {
                                 return window[movieName];
                         } else {
                                 return document[movieName];
                         }
                         }

                        function SaveState(){
                        thisMovie("flowcytoView").SaveState();
                        }

                        window.onbeforeunload =   function()
                        { SaveState();}

            var swfVersionStr = "10.0.0";
            var xiSwfUrlStr = "playerProductInstall.swf";
            var flashvars = {Swffile:"flash/2012/3q/immun_system_MM/{immun_system_MM[*,0].swf,32}"};
            var params = {};
            params.quality = "high";
            params.bgcolor = "#869ca7";
            params.allowscriptaccess = "sameDomain";
            params.allowfullscreen = "true";
            var attributes = {};
            attributes.id = "flowcytoView";
            attributes.name = "flowcytoView";
            attributes.align = "middle";
            swfobject.embedSWF(
                "flash/flowcytoview/flowcytoView.swf", "flashContent",
                "750", "600",
                swfVersionStr, xiSwfUrlStr,
                flashvars, params, attributes);
            swfobject.createCSS("#flashContent", "display:block;text-align:left;");
</script>

<div id="flashContent">
      <p>要正常查看本资料,需要安装Adobe Flash Player插件(版本号为10.0以上)</p>
       <script type="text/javascript">
                var pageHost = ((document.location.protocol == "https:") ? "https://" :        "http://");
                document.write("<a href='http://www.adobe.com/go/getflashplayer'><img src='" + pageHost + "www.adobe.com/images/shared/download_buttons/get_flash_player.gif' alt='获取 Adobe Flash player' /></a>" );
        </script>
</div>
流式中文网FlowGuard®流式专用保存液,无需冻存,稳定保护各类流式样本,从容完成实验
您需要登录后才可以回帖 登录 | 加入流式中文网

本版积分规则 需要先绑定手机号

手机版|流式中文网 ( 浙ICP备17054466号-2|浙ICP备17054466号-2 )

浙公网安备 33038202004217号

GMT+8, 2024-4-25 16:34

Powered by Discuz! X3.5

© 2001-2024 Discuz! Team.

快速回复 返回顶部 返回列表